{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:25:50Z","timestamp":1784780750130,"version":"3.55.0"},"reference-count":40,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":691,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1002\/jcph.187","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T01:26:38Z","timestamp":1381541198000},"page":"1313-1321","source":"Crossref","is-referenced-by-count":30,"title":["Effect of brivaracetam (400\u2009mg\/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women"],"prefix":"10.1002","volume":"53","author":[{"given":"Armel","family":"Stockis","sequence":"first","affiliation":[{"name":"UCB Pharma; Global Exploratory Development; Braine-l'Alleud Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rolan","sequence":"additional","affiliation":[{"name":"Medeval; Manchester UK"},{"name":"School of Medical Sciences; University of Adelaide; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"10.1002\/jcph.187-BIB0001|jcph187-cit-0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.eplepsyres.2012.10.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)","volume":"103","author":"Bialer","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1002\/jcph.187-BIB0002|jcph187-cit-0002","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/jm030913e","article-title":"Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity","volume":"47","author":"Kenda","year":"2004","journal-title":"J Med Chem."},{"key":"10.1002\/jcph.187-BIB0003|jcph187-cit-0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eplepsyres.2009.09.024","article-title":"Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture","volume":"88","author":"Zona","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1002\/jcph.187-BIB0004|jcph187-cit-0004","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1212\/WNL.0b013e3181ec7f7f","article-title":"Adjunctive brivaracetam for refractory partial-onset seizures. A randomized, controlled trial","volume":"75","author":"French","year":"2010","journal-title":"Neurology."},{"key":"10.1002\/jcph.187-BIB0005|jcph187-cit-0005","article-title":"Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from two randomized, double-blind, placebo-controlled trials","volume":"51","author":"Werhahn","year":"2010","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.187-BIB0006|jcph187-cit-0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2012.03598.x","article-title":"Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial","volume":"54","author":"van Paesschen","year":"2013","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.187-BIB0007|jcph187-cit-0007","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2125.2006.02829.x","article-title":"The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males","volume":"63","author":"Sargentini-Maier","year":"2007","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0008|jcph187-cit-0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2008.03158.x","article-title":"The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy males","volume":"66","author":"Rolan","year":"2008","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0009|jcph187-cit-0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/dmd.107.017129","article-title":"Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects","volume":"36","author":"Sargentini-Maier","year":"2008","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.187-BIB0010|jcph187-cit-0010","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1124\/dmd.112.045328","article-title":"Effect of gemfibrozil on the metabolism of brivaracetam in vitro and in human subjects","volume":"40","author":"Nicolas","year":"2012","journal-title":"Drug Metab Dispos."},{"key":"10.1002\/jcph.187-BIB0011|jcph187-cit-0011","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1177\/0091270011431457","article-title":"Brivaracetam disposition in renal impairment","volume":"52","author":"Sargentini-Maier","year":"2012","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0012|jcph187-cit-0012","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/jcph.82","article-title":"Brivaracetam disposition in mild to severe hepatic impairment","volume":"53","author":"Stockis","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0013|jcph187-cit-0013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp.72.1.114","article-title":"Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practice","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1002\/jcph.187-BIB0014|jcph187-cit-0014","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0026-895X(25)13356-7","article-title":"Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450","volume":"33","author":"Guengerich","year":"1988","journal-title":"Mol Pharmacol."},{"key":"10.1002\/jcph.187-BIB0015|jcph187-cit-0015","doi-asserted-by":"crossref","first-page":"137192","DOI":"10.1155\/2012\/137192","article-title":"Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz","volume":"2012","author":"Carten","year":"2012","journal-title":"Infect Dis Obstet Gynecol."},{"key":"10.1002\/jcph.187-BIB0016|jcph187-cit-0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00003088-199528030-00003","article-title":"Levonorgestrel clinical pharmacokinetics","volume":"28","author":"Fotherby","year":"1995","journal-title":"Clin Pharmacokinet."},{"key":"10.1002\/jcph.187-BIB0017|jcph187-cit-0017","first-page":"E62","article-title":"Contraception for women with epilepsy","volume":"6","author":"Burakgazi","year":"2009","journal-title":"Rev Neurol Dis."},{"key":"10.1002\/jcph.187-BIB0018|jcph187-cit-0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.187-BIB0019|jcph187-cit-0019","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/ecp.10.3","article-title":"Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0020|jcph187-cit-0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.seizure.2007.11.012","article-title":"Pharmacokinetic interactions between contraceptives and antiepileptic drugs","volume":"17","author":"Sabers","year":"2008","journal-title":"Seizure."},{"key":"10.1002\/jcph.187-BIB0021|jcph187-cit-0021","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/01.wnl.0000344167.78102.f0","article-title":"Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use","volume":"72","author":"Herzog","year":"2009","journal-title":"Neurology."},{"key":"10.1002\/jcph.187-BIB0022|jcph187-cit-0022","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1002\/jcph.187-BIB0023|jcph187-cit-0023","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception."},{"key":"10.1002\/jcph.187-BIB0024|jcph187-cit-0024","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0009-9236(98)90084-4","article-title":"Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations","volume":"63","author":"Kovacs","year":"1998","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.187-BIB0025|jcph187-cit-0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0010-7824(79)80038-4","article-title":"Hormonal effects of the 300 microgram norethisterone (NET) minipill. 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration","volume":"20","author":"Landgren","year":"1979","journal-title":"Contraception."},{"key":"10.1002\/jcph.187-BIB0026|jcph187-cit-0026","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02584088","article-title":"Development of the addiction research center inventory (ARCI): selection of items that are sensitive to the effects of various drugs","volume":"4","author":"Haertzen","year":"1963","journal-title":"Psychopharmacologia."},{"key":"10.1002\/jcph.187-BIB0027|jcph187-cit-0027","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","article-title":"The use of analogue scales in rating subjective feelings","volume":"47","author":"Bond","year":"1974","journal-title":"Br J Med Psychol."},{"key":"10.1002\/jcph.187-BIB0028|jcph187-cit-0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-510X(96)00231-6","article-title":"International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology","volume":"145","author":"Trouillas","year":"1997","journal-title":"J Neurol Sci."},{"key":"10.1002\/jcph.187-BIB0029|jcph187-cit-0029","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1528-1157.2002.57701.x","article-title":"Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women","volume":"43","author":"Ragueneau-Majlessi","year":"2002","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.187-BIB0030|jcph187-cit-0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF03189968","article-title":"Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report","volume":"16","author":"Shah","year":"1991","journal-title":"Eur J Drug Metab Pharmacokinet."},{"key":"10.1002\/jcph.187-BIB0031|jcph187-cit-0031","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.phrs.2005.02.014","article-title":"Study of urinary 6 beta-hydroxycortisol\/cortisol ratio in spot urine sample as a biomarker of 3A4 enzyme activity in healthy and epileptic subjects of Egyptian population","volume":"51","author":"El Desoky","year":"2005","journal-title":"Pharmacol Res."},{"key":"10.1002\/jcph.187-BIB0032|jcph187-cit-0032","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/clpt.1992.140","article-title":"Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity","volume":"52","author":"Watkins","year":"1992","journal-title":"Clin Pharmacol Ther."},{"key":"10.1002\/jcph.187-BIB0033|jcph187-cit-0033","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.2006.02628.x","article-title":"Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity","volume":"62","author":"Chen","year":"2006","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0034|jcph187-cit-0034","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol."},{"key":"10.1002\/jcph.187-BIB0035|jcph187-cit-0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1528-1167.2010.02917.x","article-title":"Carbamazepine coadministration with an oral contraceptive: effects on steroid pharmacokinetics, ovulation, and bleeding","volume":"52","author":"Davis","year":"2011","journal-title":"Epilepsia."},{"key":"10.1002\/jcph.187-BIB0036|jcph187-cit-0036","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isojarvi","year":"2005","journal-title":"CNS Drugs."},{"key":"10.1002\/jcph.187-BIB0037|jcph187-cit-0037","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet."},{"key":"10.1002\/jcph.187-BIB0038|jcph187-cit-0038","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(99)70718-0","article-title":"Causes and consequences of oral contraceptive noncompliance","volume":"180","author":"Rosenberg","year":"1999","journal-title":"Am J Obstet Gynecol."},{"key":"10.1002\/jcph.187-BIB0039|jcph187-cit-0039","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/seiz.2001.0561","article-title":"Epilepsy and the ovary (cutting out the hysteria)","volume":"10","author":"Betts","year":"2001","journal-title":"Seizure."},{"key":"10.1002\/jcph.187-BIB0040|jcph187-cit-0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.187","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcph.187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:44:43Z","timestamp":1746031483000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.187"}},"subtitle":["The Journal of Clinical Pharmacology"],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.187","relation":{},"ISSN":["0091-2700"],"issn-type":[{"value":"0091-2700","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}